NovaBay Pharmaceuticals, Inc. to Present at Southern California Investor Conference

Published: Aug 01, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., July 31, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biotechnology company focused on the topical, anti-infective market, today announced that Thomas J. Paulson, Chief Financial Officer of NovaBay Pharmaceuticals, will present a corporate and clinical update at the Southern California Investor Conference, held on August 8, 2013 in Newport Beach, CA. Mr. Paulson will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.

Help employers find you! Check out all the jobs and post your resume.

Back to news